Saturday July 04 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
  • A-Z

BioNews - BioPortfolio's News Portal
Bioterrorism, Anthrax and Smallpox Headlines

Sign-up to BioPortfolio's
Bioterrorism, Anthrax and Smallpox news alerts.
Subscribe to BioWatch News Email alerts - open BioWatch PDF brochure.
Publish your news using BioNewsCast - open BioNewsCast PDF brochure.

Emergent BioSolutions Receives FDA Approval Extending Shelf Life of BioThrax Anthrax Vaccine Adsorbed to 4 Yea
Pharmacy Choice:  similar ...
National Jewish Health and Ceragenix Announce Compound Shows Promise for Treating Potentially Lethal Viral Inf
Pharma Live:  similar ...
$37 million to extend regional biodefense and emerging infectious diseases research
Washington University in St. Louis:  similar ...
National Jewish Health And Ceragenix Announce Compound Shows Promise For Treating Potentially Lethal Viral Inf
Medical News Today:  similar ...
National Jewish Health and Ceragenix Announce Compound Shows Promise for Treating Potentially Lethal Viral Inf
DiGiTAL50:  similar ...
National Jewish Health and Ceragenix Announce Compound Shows Promise for Treating Potentially Lethal Viral Inf
NewsBlaze:  similar ...
National Jewish Health and Ceragenix Announce Compound Shows Promise for Treating Potentially Lethal Viral Inf
Genetic Engineering News:  similar ...
Emergent BioSolutions Receives FDA Approval Extending Shelf Life Of BioThrax (Anthrax Vaccine Adsorbed) To 4 Y
Medical News Today:  similar ...
Emergent BioSolutions Receives FDA Approval Extending Shelf Life of BioThrax (Anthrax Vaccine Adsorbed) to 4 Y
Pharmacy Choice:  similar ...
Response Biomedical Corporation Announces Appointment of Vice President Finance & Administration and Chief Fin
KSLA:  similar ...
Response Biomedical Corporation Announces Appointment of Vice President Finance & Administration and Chief Fin
TickerTech.com:  similar ...
Response Biomedical Corporation Announces Appointment of Vice President Finance & Administration and Chief Fin
Montana's News Station:  similar ...
HUMAN GENOME SCIENCES SUBMITS BIOLOGICS LICENSE APPLICATION TO FDA FOR ABTHRAX more CALENDAR OF EVENTS
Human Genome Sciences:  similar ...
Texas Emerging Technology Fund makes $250,000 Investment into Pulmotect
Pharma Live:  similar ...
Response Biomedical Corporation Announces Appointment of Vice President Finance & Administration and Chief Fin
KLFY:  similar ...
American Society for Microbiology honors James W. Snyder
Genetic Engineering News:  similar ...
Emergent BioSolutions Receives FDA Approval Extending Shelf Life of BioThrax (Anthrax Vaccine Adsorbed) to 4 Y
DiGiTAL50:  similar ...
Emergent BioSolutions Receives FDA Approval Extending Shelf Life of BioThrax (Anthrax Vaccine Adsorbed) to 4 Y
Genetic Engineering News:  similar ...
Emergent BioSolutions Receives FDA Approval Extending Shelf Life of BioThrax (Anthrax Vaccine Adsorbed) to 4
PR inside:  similar ...
Emergent BioSolutions Receives FDA Approval Extending Shelf Life of BioThrax (Anthrax Vaccine Adsorbed) to 4 Y
Yahoo!:  similar ...

Search BioNews

      ---Advanced searching---

Sign-up to BioPortfolio's Bioterrorism, Anthrax and Smallpox news alerts.
Subscribe to BioWatch News Email alerts - open BioWatch PDF brochure.
Publish your news using BioNewsCast - open BioNewsCast PDF brochure.

 

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright © 1997-2009 - BioPortfolio Limited.